The emergence of the Omicron variant in November 2021 was a stark reminder of the high overall cost of the persistence globally of extremely unequal access to vaccines and treatments. What are the reasons for these failures of global collective action?
This Policy Contribution assesses the rationale for a Health Union. Section 1 provides a historical perspective on health provisions in the European Union treaties. Section 2 gives an overview of the achievements of EU health policies. Section 3 explores the need for an overall health strategy and section 4 identifies the areas that would benefit from closer integration.
An analysis of the incentive effects of COVID certificates on vaccine uptake, health outcomes and the economy.
Statement published in the renowned British Medical Journal (BMJ) to address the wave of the Omicron variant of SARS-CoV-2.
How can the background of mRNA technology development help us understand how public vaccine research and development policy can be improved to generate the full global social benefits from breakthrough novel vaccine technologies?
Article published in Lancet Global Heath on strategies to end the COVID-19 pandemic in the presence of effective vaccines.
The G20 is not doing enough to support strong, balanced, sustainable and inclusive growth in the wake of COVID-19, with the poorest countries left behind by the recovery.
Agreement is needed at international level on mechanisms to ensure better preparedness for the next pandemic.
The new German government should play its part in global health security and preparedness.
Bruegel Annual Meetings, Day 1- How do we exit the COVID-19 pandemic and ensure the world of tomorrow is less vulnerable to future pandemics?
A content-based tax on the revenue from digital advertising is needed to prevent the monetisation of fake news by both creators and platforms.
COVID-19 has reinforced traditional vaccine production patterns, but the global vaccine trade has changed considerably.